The latest green light will boost Cialis sales which are already pretty healthy. Third-quarter turnover of the drug came in at $482.1 million (+3%).
- Cialis was approved for daily use for ED in 2008.
- The drug’s long duration allows for more natural sexual experiences.
- Daily Cialis dosage is usually 2.5 or 5 mg per day.
- Lifestyle changes may enhance Cialis effectiveness.
- Men with diabetes may benefit from Cialis for ED.
- Cialis can also improve exercise capacity in pulmonary hypertension patients.
- Typical adverse reactions resolve quickly with dose adjustments.
- Cialis clinical data show improvement in men with spinal cord injuries.
- Cialis does not cure ED but manages symptoms effectively.
- Patient counseling is crucial for safe Cialis use.
- Lilly promotes Cialis as part of sexual health awareness.
- Cialis use requires prior medical evaluation to rule out contraindications.
Cialis, a popular drug that treats erectile dysfunction, is distributed by Eli Lilly in Australia, Canada, New Zealand, the United Kingdom, the United States — and other countries. Although pharmacies in our program sell Cialis distributed by Eli Lilly, we cannot guarantee that Eli Lilly made it. That's because sometimes drug companies make their own medication, and in other cases, they work with a contract manufacturer.
16. How is Cialis supplied
According to IQVIA data, the total sales of Cialis in Taiwan for the last 12 months as of December 31, 2021 were approximately $15.7 million. The Company believes the majority of Cialis sales are driven by cialis without prescription in canada drugstore channel. Cialis is the 2nd largest brand by revenue in Taiwan indicated for erectile dysfunction with very high brand loyalty. The acquisition will accelerate Lotus's growth and sets a very strong foundation for entry in the high growth drugstore channel. Thermo Fisher Scientific opens flag..
5.6 Alpha-blockers and Antihypertensives
29 April 2026 Amcor invests $35 M in advanced hea.. 26 April 2026 Singapore and Japan deepen collabor.. 23 April 2026 Japan's Takeda terminates mRNA-targ.. 18 April 2026 Regulators in Europe have given the green light to Eli Lilly’s erectile dysfunction drug Cialis as a treatment for enlarged prostate. The European Commission has approved Cialis (tadalafil) for once-daily use for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). We did a little digging on where Cialis is made..
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Cialis Professional | 20mg | 10 Pills | 48.29€ 45.99€ | |
| Cialis Generic | 20mg | 20 Pills | 54.72€ 52.11€ | |
| Cialis Generic | 20mg | 60 + 6 Pills | 117.76€ 112.15€ | |
| Cialis Generic | 10mg | 20 Pills | 48.23€ 45.93€ | |
| Cialis Generic | 60mg | 360 + 10 Pills | 570.52€ 543.35€ | |
| Cialis Generic | 2.5mg | 90 + 6 Pills | 112.43€ 107.08€ | |
| Cialis Generic | 5mg | 30 + 4 Pills | 53.56€ 51.01€ | |
| Cialis Original | 20mg | 76 + 4 Pills | 319.19€ 303.99€ | |
| Cialis Generic | 2.5mg | 10 Pills | 28.51€ 27.15€ | |
| Cialis Generic | 60mg | 180 + 10 Pills | 313.11€ 298.20€ | |
| Cialis Soft Tabs | 20mg | 10 Pills | 39.03€ 37.17€ | |
| Cialis Super Active | 20mg | 10 Pills | 55.64€ 52.99€ |
According to representatives of Eli Lilly, the Cialis sold in Canada and the U.S.
Highlights of Prescribing Information
With Cialis®, Menarini intends to strategically expand its nationwide coverage across the Retail, E-Commerce and Hospital channels and deliver on its growth ambition in the second-largest healthcare market worldwide. Besides Men’s Health, Menarini is focused on major therapeutic categories including Dermatology, Allergy/Respiratory, Cardiovascular, Gastroenterology, Pain Management, Consumer Healthcare, Oncology and Anti-Infectives. Maurizio Luongo, Chief Executive Officer, Menarini Asia-Pacific said, “The acquisition of Cialis® is a testament to Menarini’s commitment to invest and grow our well diversified Primary and Speciality Care portfolio in the Asia-Pacific region, which is an increasingly important engine of growth for the Group. We are excited to take the brand from strength to strength in China with our well proven, multi-pronged go-to-market strategy for our Men’s Health portfolio in China. We look forward to harnessing the combined strengths of the complementary products in this portfolio to invigorate lives and relationships across the nation.” Cialis is indicated in China for the treatment of men with erectile dysfunction (ED), and men with both ED and the signs and symptoms of benign prostatic hyperplasia.
Adverse Reactions/Side Effects
It is important to note that Cialis is not to be taken with medicines called "nitrates" such as nitroglycerin, as tadalafil may potentiate the hypotensive effect of nitrates; and also GC stimulator, such as riociguat. Menarini Asia-Pacific is a member of the Menarini Group, with a heritage of over 130 years and over 17,000 employees in more than 140 countries. Here in Asia-Pacific, Menarini’s vision is to be a leading provider of important healthcare brands to improve the lives of people in the region. Menarini Asia-Pacific operates across the entire commercial value chain, from clinical development, regulatory approval and product launch to lifecycle management with a diverse portfolio of proprietary and partnered brands in key therapeutic fields, including Consumer Health, Dermatology, Allergy/Respiratory, Gastroenterology, Cardio-metabolic, Anti-infectives, Oncology/Specialty Care and Men’s Health. For the Financial Year 2020, the Menarini Group clocked sales revenues of US 4.6 billion dollars, of which the Asia Pacific region has grown to become a dynamic engine of growth for the Group with more than 10% revenue contribution.
5.9 Alcohol
For more information about Menarini Asia-Pacific, please visit: If you'd like to know more about Menarini, feel free to download our PDF files here. Lotus Pharmaceuticals has acquired trademark, marketing authorization, and manufacturing know-how of Tadalafil 2.5mg, 5mg, 10mg and 20mg under the brand name of Cialis in Taiwan for $57.5 million from Eli Lilly and Company. Immediately upon closing the transaction, the company will take over the Cialis business. The completion of this transaction is subject to customary closing conditions. Tadalafil is indicated for the treatment of erectile dysfunction and benign prostatic hyperplasia, and Cialis is positioned as the top 2 brand product for erectile dysfunction treatment with high brand loyalty. is manufactured in Puerto Rico. We also learned that the Canadian version is packaged in Indiana. Despite this, the prices for Cialis are much higher in the U.S. Cialis is much more expensive in the U.S. than in other countries.
- Cialis introduction changed the landscape of erectile dysfunction treatment.
- It offered an alternative with longer duration than prior PDE5 inhibitors.
- Market acceptance was driven by favorable patient and clinician feedback.
- Some men prefer Cialis due to reduced planning for sexual activity.
- The drug's patent provided Lilly a commercial advantage for years.
- Extensive advertising targeted both physicians and consumers.
- Patient support groups often discuss experiences with Cialis.
- Alternative ED treatments include injections, vacuum pumps, and surgery.
- Cialis fits a broad spectrum of ED severity levels.
- Diabetes, hypertension, and heart disease are common conditions with Cialis use.
- Lilly continues efforts to educate about safe sexual health practices.
- Ongoing clinical trials explore broader uses of tadalafil.
The average per pill cost of Cialis 5 mg in the U.S is $13.03, compared to as low as $4.44 in Canada and $4.36 in the UK.
2.2 CIALIS for Once Daily Use for Erectile Dysfunction
Medicines are sometimes prescribed for conditions other than those described in patient information leaflets. Do not use CIALIS for a condition for which it was not prescribed. Do not give CIALIS to other people, even if they have the same symptoms that you have. This is a summary of the most important information about CIALIS. If you would like more information, talk with your healthcare provider.
1.2 Benign Prostatic Hyperplasia
You can ask your healthcare provider or pharmacist for information about CIALIS that is written for health providers. For more information you can also visit or call 1-877-CIALIS1 (1-877-242-5471). This Patient Information has been approved by the U.S. Food and Drug Administration CIALIS® (tadalafil) is a registered trademark of Eli Lilly and Company. *The brands listed are trademarks of their respective owners and are not trademarks of Eli Lilly and Company.
Related treatment guides
The makers of these brands are not affiliated with and do not endorse Eli Lilly and Company or its products. Marketed by: Lilly USA, LLCIndianapolis, IN 46285, USA PACKAGE LABEL – Cialis 5mg tablets, 30 count, bottle Cialis vs Viagra - What's the difference between them? Can you take Cialis and Viagra together? Why does Cialis take at least 12-14 hours to work? Is taking Cialis 40 mg daily safe? We strongly recommend that you do not buy Cialis online from websites that have not been verified by PharmacyChecker.com or another qualified credentialing group. For more on what we do to verify the safety of online pharmacies, please read our post on why you can trust PharmacyChecker.com.
5.9 Alcohol
Leverage our omni-channel approach to grow your brand across Asia Pacific. The healthcare sector in Asia Pacific is rapidly growing. As part of the world’s leading Italian biopharmaceutical company, Menarini AP has a strong presence in 13 key markets across the region. As a partner of choice for numerous global healthcare companies, we engage in the entire pharmaceutical development lifecycle to tap growth opportunities and grow their brand footprint. In doing so, we also support healthcare professionals and patients with quality medical products and technology to raise standards and invigorate lives for tomorrow.
Comparison with actions of other PDE5 inhibitors
A. MENARINI ASIA-PACIFIC HOLDINGS PTE LTD A. MENARINI ASIA-PACIFIC PRIVATE LIMITED A. MENARINI SINGAPORE PTE LTD A. MENARINI BIOMARKERS SINGAPORE PTE LTD Acquisition of Cialis® in the People’s Republic of China to bolster Menarini’s Men’s Health portfolio and drive multichannel coverage This is a significant milestone for Menarini Asia operations as it commemorates its 10th anniversary of being established in 13 major healthcare markets in Asia-Pacific 22/07/21, Singapore – A.
7.2 Potential for Other Drugs to Affect CIALIS
Menarini Asia-Pacific Holdings Pte. Ltd., part of the Menarini Group, the world’s largest Italian biopharmaceutical company, announced today the completion of its acquisition of Cialis® in the People’s Republic of China from Eli Lilly and Company. Through the acquisition, Menarini will take over ownership of the brand and assume all sales, marketing and distribution responsibilities. Cialis® was first approved by the European Medicines Agency in 2002 followed by the U.S. Food and Drug Administration (“FDA”) in 2003 and then NMPA (National Medical Products Administration) in cialis professional order 2005, as well as in more than 120 other countries. You can find more information related to Cialis, generic Cialis and online savings on the PharmacyChecker Blog.
- Cialis tablets come with different packaging, including blister packs and bottles.
- Eli Lilly provides comprehensive patient information leaflets with Cialis.
- Cialis is sometimes prescribed off-label for Raynaud’s phenomenon.
- The medication has a bioavailability of about 80%.
- Food intake has minimal impact on Cialis absorption.
- Cialis is metabolized primarily by the liver enzyme CYP3A4.
- Dose adjustments might be necessary for patients with kidney impairment.
- Cialis’s half-life is approximately 17.5 hours, contributing to long effect.
- Lilly has faced generic competition for Cialis in many markets.
- The drug’s patent expiration allowed entry of tadalafil generics.
- Cialis is included in some clinical guidelines for ED management.
- Monitoring for rare but serious side effects is part of patient care.
Eli Lilly doesn't expect to see generic competition to its second best-selling drug Cialis (tadalafil) until after September 2018, announcing Wednesday it had entered into a settlement agreement with generic drugmakers to resolve pending patent litigation over the erectile dysfunction treatment.
- The Cialis patent expired in many countries by the mid-2020s.
- Generic tadalafil versions became widely accessible to patients.
- Market competition led to reduced prices for Cialis and generics.
- Lilly continues research on improved formulations of tadalafil.
- Online pharmacies sell Cialis; caution is advised to avoid counterfeits.
- The drug should only be purchased through licensed distributors.
- Awareness campaigns educate about safe use of Cialis.
- Side effect profiles remain similar between brand and generic versions.
- Pharmacovigilance monitors adverse events linked to Cialis use.
- Cialis remains an important option in ED treatment algorithms.
- The medication plays a role in men's sexual health discussions.
- Physicians frequently review Cialis use during follow-up visits.
Lilly had been battling generic companies in federal district court over a patent covering Cialis' unit dose, which was previously due to expire in April 2020.
| Use Case | Description | Notes |
|---|---|---|
| Erectile Dysfunction (ED) | Improves ability to achieve/maintain erection | Most common use |
| Pulmonary Arterial Hypertension | Reduces blood pressure in lungs | Prescribed under different dose |
| Benign Prostatic Hyperplasia | Relieves urinary symptoms | Off-label use |
| Raynaud's Phenomenon | Relaxes blood vessels | Experimental treatment |
Under the settlement agreement, Cialis exclusivity will end at the earliest on September 27, 2018. That date is nearly a year after Lilly expects to lose patent protection on other compound and use patents which cover the drug through November 2017.
14. Clinical Studies
The drug was approved for ED in the EU in 2002, and the latest thumbs-up comes just over a year after the US Food and Drug Administration cleared Cialis for BPH. Anthony Beardsworth, senior medical director at Lilly, said that with this approval, “Cialis is now the only medication in the EU to provide a single treatment option for men with both ED and BPH”. He noted that since many men with ED suffer from the latter, a single drug to treat both “may be a useful therapeutic option”. Lilly added that Cialis should not be used in patients taking nitrates, because the combination can cause an unsafe decrease in blood pressure. In addition to the USA and the EU, Cialis is approved for BPH in Canada, Mexico, Brazil, South Korea, Russia, Panama, Argentina, Honduras, Ecuador, Costa Rica, Colombia and Israel.